Back

Transaortic flow rate to predict short and long term outcomes in individuals with asymptomatic aortic stenosis.

26 August 2022 (11:15 - 12:00)
Organised by:
Congress Presentation Part of: What is new in valvular heart disease assessed with echocardiography? Valvular Heart Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Susil Pallikadavath

NIHR Biomedical Research Unit in Cardiovascular Disease, Leicester (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Pressure-recovery adjustment of aortic valve area does not improve risk prediction in aortic stenosis
Doctor T. Lindow (Vaxjo, SE)
Abstract Slides
Presentation thumbnail
The mitral to aortic/pulmonary velocity-time integral ratio is a simple, feasible and accurate discriminator for echocardiographic evaluation of severe isolated mitral regurgitation.
Doctor S. Ramkumar (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Atrial functional mitral regurgitation during exercise is associated with impaired longitudinal left ventricular systolic function and annular dilation: an exercise echocardiographic study.
Ms S. De Schutter (Antwerp, BE)
Abstract Slides
Presentation thumbnail
Optimal CW-Doppler derived parameter for the diagnosis of iatrogenic mitral stenosis during transcatheter edge-to-edge repair for mitral regurgitation
Doctor N. Brugger (Bern, CH)
Abstract Slides
Presentation thumbnail
Sex-based differences of the impact of aortic valve calcium score on mortality and post-procedural outcomes after trans-catheter aortic valve replacement
Doctor M. Ahsan (West Des Moines, US)
Abstract Slides

Access the full session

Session thumbnail
What is new in valvular heart disease assessed with echocardiography?

The Event

Event poster

ESC Congress 2022

26 August 2022 11:15 CET
You may be interested in
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Session
Acute heart failure and valvular heart disease
thumbnail
Congress Session
How to manage valvular heart disease in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources